25 XP   0   0   10

Medistim ASA
Buy, Hold or Sell?

Let's analyse Medistim together

PenkeI guess you are interested in Medistim ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Medistim ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Medistim ASA

I send you an email if I find something interesting about Medistim ASA.

Quick analysis of Medistim (30 sec.)










What can you expect buying and holding a share of Medistim? (30 sec.)

How much money do you get?

How much money do you get?
kr1.22
When do you have the money?
1 year
How often do you get paid?
65.0%

What is your share worth?

Current worth
kr21.74
Expected worth in 1 year
kr23.39
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
kr15.12
Return On Investment
8.4%

For what price can you sell your share?

Current Price per Share
kr181.00
Expected price per share
kr176.00 - kr204.00
How sure are you?
50%

1. Valuation of Medistim (5 min.)




Live pricePrice per Share (EOD)

kr181.00

Intrinsic Value Per Share

kr24.34 - kr61.86

Total Value Per Share

kr46.08 - kr83.60

2. Growth of Medistim (5 min.)




Is Medistim growing?

Current yearPrevious yearGrowGrow %
How rich?$36m$30.5m$4m11.7%

How much money is Medistim making?

Current yearPrevious yearGrowGrow %
Making money$2.3m$2.5m-$229.8k-9.8%
Net Profit Margin19.9%23.2%--

How much money comes from the company's main activities?

3. Financial Health of Medistim (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#186 / 339

Most Revenue
#186 / 339

Most Profit
#89 / 339

What can you expect buying and holding a share of Medistim? (5 min.)

Welcome investor! Medistim's management wants to use your money to grow the business. In return you get a share of Medistim.

What can you expect buying and holding a share of Medistim?

First you should know what it really means to hold a share of Medistim. And how you can make/lose money.

Speculation

The Price per Share of Medistim is kr181.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medistim.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medistim, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr21.74. Based on the TTM, the Book Value Change Per Share is kr0.41 per quarter. Based on the YOY, the Book Value Change Per Share is kr3.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr3.37 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medistim.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.090.1%0.140.1%0.140.1%0.110.1%0.080.0%
Usd Book Value Change Per Share0.100.1%0.040.0%0.280.2%0.050.0%0.030.0%
Usd Dividend Per Share0.000.0%0.310.2%0.370.2%0.250.1%0.160.1%
Usd Total Gains Per Share0.100.1%0.340.2%0.660.4%0.300.2%0.200.1%
Usd Price Per Share19.39-22.79-22.29-21.04-13.05-
Price to Earnings Ratio51.25-42.26-40.21-56.43-40.66-
Price-to-Total Gains Ratio199.12-105.59-48.79-106.72-78.18-
Price to Book Ratio9.84-12.09-13.48-15.61-10.95-
Price-to-Total Gains Ratio199.12-105.59-48.79-106.72-78.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share16.3986
Number of shares60
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.310.25
Usd Book Value Change Per Share0.040.05
Usd Total Gains Per Share0.340.30
Gains per Quarter (60 shares)20.5517.96
Gains per Year (60 shares)82.1971.83
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
173972601162
21461815412123134
32202723618134206
42933631824245278
53664540030257350
64395448236368422
75126356442379494
85867264648491566
965981728544102638
1073290810605114710

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%60.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%14.06.00.070.0%29.011.00.072.5%42.015.03.070.0%
Dividend per Share3.00.01.075.0%11.00.01.091.7%17.00.03.085.0%26.00.014.065.0%26.00.034.043.3%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%36.04.00.090.0%49.08.03.081.7%

Fundamentals of Medistim

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. It operates through Sale of Own Products; and Sale of 3. Party Products segments. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; MiraQ Ultimate, which uses flow measurement and ultrasound imaging probes to provide a complete assessment; and imaging probes for intraoperative use. It also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical devices. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Fundamental data was last updated by Penke on 2024-04-01 13:21:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Medistim ASA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medistim earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Medistim to the Medical Devices industry mean.
  • A Net Profit Margin of 14.7% means that kr0.15 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medistim ASA:

  • The MRQ is 14.7%. The company is making a huge profit. +2
  • The TTM is 19.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.7%TTM19.9%-5.2%
TTM19.9%YOY23.2%-3.3%
TTM19.9%5Y20.8%-0.9%
5Y20.8%10Y18.2%+2.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7%-11.2%+25.9%
TTM19.9%-19.6%+39.5%
YOY23.2%-14.4%+37.6%
5Y20.8%-21.3%+42.1%
10Y18.2%-24.8%+43.0%
1.1.2. Return on Assets

Shows how efficient Medistim is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medistim to the Medical Devices industry mean.
  • 3.8% Return on Assets means that Medistim generated kr0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medistim ASA:

  • The MRQ is 3.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 5.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ3.8%TTM5.5%-1.7%
TTM5.5%YOY6.6%-1.1%
TTM5.5%5Y5.9%-0.4%
5Y5.9%10Y5.4%+0.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8%-4.0%+7.8%
TTM5.5%-4.5%+10.0%
YOY6.6%-4.8%+11.4%
5Y5.9%-4.0%+9.9%
10Y5.4%-5.2%+10.6%
1.1.3. Return on Equity

Shows how efficient Medistim is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medistim to the Medical Devices industry mean.
  • 4.8% Return on Equity means Medistim generated kr0.05 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medistim ASA:

  • The MRQ is 4.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 6.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.8%TTM6.9%-2.1%
TTM6.9%YOY8.5%-1.6%
TTM6.9%5Y7.6%-0.7%
5Y7.6%10Y7.2%+0.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8%-3.9%+8.7%
TTM6.9%-5.6%+12.5%
YOY8.5%-5.9%+14.4%
5Y7.6%-6.1%+13.7%
10Y7.2%-7.1%+14.3%

1.2. Operating Efficiency of Medistim ASA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medistim is operating .

  • Measures how much profit Medistim makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medistim to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medistim ASA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM7.7%-7.7%
TTM7.7%YOY29.1%-21.4%
TTM7.7%5Y23.0%-15.4%
5Y23.0%10Y22.6%+0.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--22.8%+22.8%
TTM7.7%-17.1%+24.8%
YOY29.1%-13.4%+42.5%
5Y23.0%-19.2%+42.2%
10Y22.6%-24.0%+46.6%
1.2.2. Operating Ratio

Measures how efficient Medistim is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.09 means that the operating costs are kr1.09 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Medistim ASA:

  • The MRQ is 1.091. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.963. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.091TTM0.963+0.128
TTM0.963YOY0.866+0.097
TTM0.9635Y0.807+0.157
5Y0.80710Y0.796+0.010
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0911.428-0.337
TTM0.9631.426-0.463
YOY0.8661.503-0.637
5Y0.8071.440-0.633
10Y0.7961.371-0.575

1.3. Liquidity of Medistim ASA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medistim is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 4.15 means the company has kr4.15 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Medistim ASA:

  • The MRQ is 4.153. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.236. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.153TTM4.236-0.083
TTM4.236YOY4.277-0.041
TTM4.2365Y4.175+0.061
5Y4.17510Y3.629+0.546
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1532.787+1.366
TTM4.2362.763+1.473
YOY4.2773.488+0.789
5Y4.1753.617+0.558
10Y3.6293.514+0.115
1.3.2. Quick Ratio

Measures if Medistim is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medistim to the Medical Devices industry mean.
  • A Quick Ratio of 0.79 means the company can pay off kr0.79 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medistim ASA:

  • The MRQ is 0.788. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.104. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.788TTM2.104-1.316
TTM2.104YOY2.950-0.846
TTM2.1045Y2.471-0.367
5Y2.47110Y1.899+0.573
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7881.539-0.751
TTM2.1041.660+0.444
YOY2.9502.139+0.811
5Y2.4712.300+0.171
10Y1.8992.255-0.356

1.4. Solvency of Medistim ASA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medistim assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medistim to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.21 means that Medistim assets are financed with 21.3% credit (debt) and the remaining percentage (100% - 21.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Medistim ASA:

  • The MRQ is 0.213. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.204. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.213TTM0.204+0.009
TTM0.204YOY0.224-0.020
TTM0.2045Y0.227-0.023
5Y0.22710Y0.248-0.021
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2130.389-0.176
TTM0.2040.386-0.182
YOY0.2240.338-0.114
5Y0.2270.442-0.215
10Y0.2480.460-0.212
1.4.2. Debt to Equity Ratio

Measures if Medistim is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medistim to the Medical Devices industry mean.
  • A Debt to Equity ratio of 27.1% means that company has kr0.27 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medistim ASA:

  • The MRQ is 0.271. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.257. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.271TTM0.257+0.014
TTM0.257YOY0.289-0.032
TTM0.2575Y0.295-0.038
5Y0.29510Y0.335-0.041
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2710.559-0.288
TTM0.2570.560-0.303
YOY0.2890.478-0.189
5Y0.2950.624-0.329
10Y0.3350.674-0.339

2. Market Valuation of Medistim ASA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Medistim generates.

  • Above 15 is considered overpriced but always compare Medistim to the Medical Devices industry mean.
  • A PE ratio of 51.25 means the investor is paying kr51.25 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medistim ASA:

  • The EOD is 43.349. Based on the earnings, the company is overpriced. -1
  • The MRQ is 51.252. Based on the earnings, the company is expensive. -2
  • The TTM is 42.265. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD43.349MRQ51.252-7.903
MRQ51.252TTM42.265+8.988
TTM42.265YOY40.211+2.053
TTM42.2655Y56.433-14.168
5Y56.43310Y40.656+15.777
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD43.349-1.037+44.386
MRQ51.252-1.578+52.830
TTM42.265-2.041+44.306
YOY40.211-2.971+43.182
5Y56.433-2.058+58.491
10Y40.656-1.463+42.119
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Medistim ASA:

  • The EOD is 88.424. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 104.545. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 572.586. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD88.424MRQ104.545-16.121
MRQ104.545TTM572.586-468.041
TTM572.586YOY58.190+514.396
TTM572.5865Y162.249+410.337
5Y162.24910Y82.300+79.950
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD88.424-1.007+89.431
MRQ104.545-1.544+106.089
TTM572.586-3.018+575.604
YOY58.190-6.339+64.529
5Y162.249-4.928+167.177
10Y82.300-4.950+87.250
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medistim is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 9.84 means the investor is paying kr9.84 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Medistim ASA:

  • The EOD is 8.326. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.844. Based on the equity, the company is overpriced. -1
  • The TTM is 12.085. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.326MRQ9.844-1.518
MRQ9.844TTM12.085-2.241
TTM12.085YOY13.478-1.393
TTM12.0855Y15.611-3.526
5Y15.61110Y10.950+4.661
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD8.3261.987+6.339
MRQ9.8442.379+7.465
TTM12.0852.444+9.641
YOY13.4783.215+10.263
5Y15.6113.833+11.778
10Y10.9504.163+6.787
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Medistim ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.0750.413+160%3.137-66%0.522+106%0.377+185%
Book Value Per Share--21.73820.886+4%18.439+18%15.952+36%12.295+77%
Current Ratio--4.1534.236-2%4.277-3%4.175-1%3.629+14%
Debt To Asset Ratio--0.2130.204+4%0.224-5%0.227-6%0.248-14%
Debt To Equity Ratio--0.2710.257+6%0.289-6%0.295-8%0.335-19%
Dividend Per Share---3.367-100%4.113-100%2.781-100%1.781-100%
Eps--1.0441.517-31%1.556-33%1.220-14%0.904+15%
Free Cash Flow Per Share--0.5121.140-55%1.262-59%1.101-54%0.782-35%
Free Cash Flow To Equity Per Share--0.512-2.348+559%0.302+70%-0.234+146%-0.072+114%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--61.861--------
Intrinsic Value_10Y_min--24.338--------
Intrinsic Value_1Y_max--5.156--------
Intrinsic Value_1Y_min--3.030--------
Intrinsic Value_3Y_max--16.287--------
Intrinsic Value_3Y_min--8.647--------
Intrinsic Value_5Y_max--28.376--------
Intrinsic Value_5Y_min--13.717--------
Market Cap3313422200.000-18%3917526800.0004604009300.000-15%4503325200.000-13%4660934495.000-16%2841027165.500+38%
Net Profit Margin--0.1470.199-26%0.232-37%0.208-29%0.182-20%
Operating Margin---0.077-100%0.291-100%0.230-100%0.226-100%
Operating Ratio--1.0910.963+13%0.866+26%0.807+35%0.796+37%
Pb Ratio8.326-18%9.84412.085-19%13.478-27%15.611-37%10.950-10%
Pe Ratio43.349-18%51.25242.265+21%40.211+27%56.433-9%40.656+26%
Price Per Share181.000-18%214.000251.500-15%246.000-13%232.225-8%144.003+49%
Price To Free Cash Flow Ratio88.424-18%104.545572.586-82%58.190+80%162.249-36%82.300+27%
Price To Total Gains Ratio168.416-18%199.122105.586+89%48.791+308%106.720+87%78.182+155%
Quick Ratio--0.7882.104-63%2.950-73%2.471-68%1.899-58%
Return On Assets--0.0380.055-31%0.066-43%0.059-36%0.054-30%
Return On Equity--0.0480.069-30%0.085-43%0.076-36%0.072-33%
Total Gains Per Share--1.0753.780-72%7.250-85%3.304-67%2.158-50%
Usd Book Value--36053454.60034639573.650+4%30581690.250+18%27218808.510+32%20772928.815+74%
Usd Book Value Change Per Share--0.0970.037+160%0.284-66%0.047+106%0.034+185%
Usd Book Value Per Share--1.9691.892+4%1.671+18%1.445+36%1.114+77%
Usd Dividend Per Share---0.305-100%0.373-100%0.252-100%0.161-100%
Usd Eps--0.0950.137-31%0.141-33%0.111-14%0.082+15%
Usd Free Cash Flow--848740.8001890436.950-55%2092610.850-59%1914817.410-56%1341129.150-37%
Usd Free Cash Flow Per Share--0.0460.103-55%0.114-59%0.100-54%0.071-35%
Usd Free Cash Flow To Equity Per Share--0.046-0.213+559%0.027+70%-0.021+146%-0.007+114%
Usd Market Cap300196051.320-18%354927928.080417123242.580-15%408001263.120-13%422280665.247-16%257397061.194+38%
Usd Price Per Share16.399-18%19.38822.786-15%22.288-13%21.040-8%13.047+49%
Usd Profit--1731275.4002351590.950-26%2581488.450-33%2031197.640-15%1503463.965+15%
Usd Revenue--11810978.40011803118.850+0%11142373.050+6%9712247.520+22%7904718.630+49%
Usd Total Gains Per Share--0.0970.342-72%0.657-85%0.299-67%0.196-50%
 EOD+4 -4MRQTTM+12 -23YOY+11 -245Y+15 -2010Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Medistim ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1543.349
Price to Book Ratio (EOD)Between0-18.326
Net Profit Margin (MRQ)Greater than00.147
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.788
Current Ratio (MRQ)Greater than14.153
Debt to Asset Ratio (MRQ)Less than10.213
Debt to Equity Ratio (MRQ)Less than10.271
Return on Equity (MRQ)Greater than0.150.048
Return on Assets (MRQ)Greater than0.050.038
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Medistim ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.277
Ma 20Greater thanMa 50188.900
Ma 50Greater thanMa 100196.740
Ma 100Greater thanMa 200203.990
OpenGreater thanClose188.500
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in NOK. All numbers in thousands.

Summary
Total Assets505,718
Total Liabilities107,777
Total Stockholder Equity397,941
 As reported
Total Liabilities 107,777
Total Stockholder Equity+ 397,941
Total Assets = 505,718

Assets

Total Assets505,718
Total Current Assets391,566
Long-term Assets114,152
Total Current Assets
Cash And Cash Equivalents 146,082
Net Receivables 74,303
Inventory 145,391
Total Current Assets  (as reported)391,566
Total Current Assets  (calculated)365,776
+/- 25,790
Long-term Assets
Property Plant Equipment 57,306
Goodwill 14,128
Intangible Assets 31,246
Long-term Assets  (as reported)114,152
Long-term Assets  (calculated)102,680
+/- 11,472

Liabilities & Shareholders' Equity

Total Current Liabilities94,284
Long-term Liabilities13,493
Total Stockholder Equity397,941
Total Current Liabilities
Accounts payable 25,083
Other Current Liabilities 1,413
Total Current Liabilities  (as reported)94,284
Total Current Liabilities  (calculated)26,496
+/- 67,788
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt17,644
Long-term Liabilities Other -1
Long-term Liabilities  (as reported)13,493
Long-term Liabilities  (calculated)17,643
+/- 4,150
Total Stockholder Equity
Retained Earnings 307,380
Total Stockholder Equity (as reported)397,941
Total Stockholder Equity (calculated)307,380
+/- 90,561
Other
Capital Stock4,585
Common Stock Shares Outstanding 18,282
Net Invested Capital 397,941
Net Working Capital 297,282
Property Plant and Equipment Gross 190,635



Balance Sheet

Currency in NOK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
145,627
144,743
131,836
134,683
145,944
147,905
141,790
140,419
149,626
153,482
147,525
148,596
151,867
153,667
154,341
157,458
168,390
168,947
173,275
181,768
203,488
205,609
238,225
200,990
218,436
219,991
195,450
206,006
217,049
228,254
213,291
227,268
251,065
252,738
217,067
233,814
269,592
285,955
258,705
282,261
336,109
363,082
368,276
394,750
345,820
365,090
332,075
362,588
403,244
427,490
397,641
432,429
482,659
499,542
441,936
474,897
505,718
505,718474,897441,936499,542482,659432,429397,641427,490403,244362,588332,075365,090345,820394,750368,276363,082336,109282,261258,705285,955269,592233,814217,067252,738251,065227,268213,291228,254217,049206,006195,450219,991218,436200,990238,225205,609203,488181,768173,275168,947168,390157,458154,341153,667151,867148,596147,525153,482149,626140,419141,790147,905145,944134,683131,836144,743145,627000
   > Total Current Assets 
0
0
0
92,979
93,417
82,073
87,155
97,126
98,986
91,961
88,252
94,020
98,742
92,261
94,979
98,635
99,970
95,262
94,986
104,930
104,687
107,131
116,261
134,955
137,392
115,650
132,792
149,156
149,937
125,114
136,310
146,947
158,826
142,706
157,900
180,231
182,079
146,437
162,000
190,450
199,535
172,310
197,499
228,501
255,319
263,813
291,484
245,787
269,674
240,921
272,540
306,497
333,543
304,221
336,107
385,894
404,484
344,336
373,305
391,566
391,566373,305344,336404,484385,894336,107304,221333,543306,497272,540240,921269,674245,787291,484263,813255,319228,501197,499172,310199,535190,450162,000146,437182,079180,231157,900142,706158,826146,947136,310125,114149,937149,156132,792115,650137,392134,955116,261107,131104,687104,93094,98695,26299,97098,63594,97992,26198,74294,02088,25291,96198,98697,12687,15582,07393,41792,979000
       Cash And Cash Equivalents 
0
0
0
29,297
33,253
20,370
26,807
34,928
36,322
26,623
26,220
29,235
31,792
20,038
22,358
24,982
27,927
11,957
16,943
17,814
20,622
27,205
33,646
46,976
51,281
28,442
35,702
46,137
43,282
18,229
21,734
28,172
41,871
19,860
27,718
50,582
56,077
20,812
35,658
43,500
54,351
28,668
49,035
62,403
85,426
102,459
114,899
65,761
86,657
53,019
89,658
124,866
147,943
104,026
124,557
144,164
149,270
90,844
126,422
146,082
146,082126,42290,844149,270144,164124,557104,026147,943124,86689,65853,01986,65765,761114,899102,45985,42662,40349,03528,66854,35143,50035,65820,81256,07750,58227,71819,86041,87128,17221,73418,22943,28246,13735,70228,44251,28146,97633,64627,20520,62217,81416,94311,95727,92724,98222,35820,03831,79229,23526,22026,62336,32234,92826,80720,37033,25329,297000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,439
56,993
59,892
68,046
62,556
62,447
62,935
67,556
76,369
72,226
69,333
64,825
69,373
72,592
62,509
63,674
60,468
68,889
74,417
76,754
73,518
88,175
95,702
108,240
118,920
104,698
116,184
81,238
74,303
74,30381,238116,184104,698118,920108,24095,70288,17573,51876,75474,41768,88960,46863,67462,50972,59269,37364,82569,33372,22676,36967,55662,93562,44762,55668,04659,89256,99354,4390000000000000000000000000000000
       Other Current Assets 
0
0
0
35,413
31,799
33,901
31,122
33,627
32,358
33,633
31,832
32,457
34,369
37,103
38,571
37,479
36,181
43,250
40,144
49,186
45,252
41,274
44,765
51,105
47,168
43,821
48,840
56,406
52,659
46,432
58,471
59,478
56,994
59,893
68,046
66,927
62,447
62,934
67,556
83,107
83,582
79,298
76,833
76,028
72,593
62,509
63,675
67,359
68,889
74,417
76,754
84,218
88,174
1
1
0
-1
0
0
0
000-101188,17484,21876,75474,41768,88967,35963,67562,50972,59376,02876,83379,29883,58283,10767,55662,93462,44766,92768,04659,89356,99459,47858,47146,43252,65956,40648,84043,82147,16851,10544,76541,27445,25249,18640,14443,25036,18137,47938,57137,10334,36932,45731,83233,63332,35833,62731,12233,90131,79935,413000
   > Long-term Assets 
0
0
0
52,648
51,326
49,763
47,528
48,818
48,919
49,829
52,167
55,606
54,740
55,264
53,617
53,232
53,697
59,079
62,472
63,460
64,260
66,144
65,507
68,533
68,217
122,575
68,198
69,280
70,054
70,336
69,696
70,102
69,428
70,585
69,368
70,834
70,659
70,630
71,814
79,142
86,420
86,395
84,762
107,608
107,763
104,463
103,266
100,033
95,416
91,154
90,048
96,747
93,947
93,420
96,322
96,764
95,058
97,601
101,592
114,152
114,152101,59297,60195,05896,76496,32293,42093,94796,74790,04891,15495,416100,033103,266104,463107,763107,60884,76286,39586,42079,14271,81470,63070,65970,83469,36870,58569,42870,10269,69670,33670,05469,28068,198122,57568,21768,53365,50766,14464,26063,46062,47259,07953,69753,23253,61755,26454,74055,60652,16749,82948,91948,81847,52849,76351,32652,648000
       Property Plant Equipment 
0
0
0
5,990
6,192
6,233
5,682
5,244
5,543
6,776
8,956
9,767
9,228
10,417
9,615
10,944
11,434
13,561
13,926
14,062
13,542
13,247
13,204
15,276
15,094
15,414
14,804
14,159
14,707
16,469
16,501
18,405
19,208
22,072
23,033
25,744
26,256
27,040
29,205
32,199
44,598
44,764
43,819
64,892
68,721
66,568
67,890
64,684
63,372
60,329
59,406
58,862
60,097
58,274
59,941
51,312
53,082
52,955
54,014
57,306
57,30654,01452,95553,08251,31259,94158,27460,09758,86259,40660,32963,37264,68467,89066,56868,72164,89243,81944,76444,59832,19929,20527,04026,25625,74423,03322,07219,20818,40516,50116,46914,70714,15914,80415,41415,09415,27613,20413,24713,54214,06213,92613,56111,43410,9449,61510,4179,2289,7678,9566,7765,5435,2445,6826,2336,1925,990000
       Goodwill 
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
14,128
0
14,128
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
0
0
14,128
0
14,128
14,128
14,128
14,12814,12814,128014,12800014,12800014,12800014,12800014,12800014,12800014,12800014,128014,128014,12800014,12800014,12800014,12800014,12800014,128000
       Intangible Assets 
0
0
0
19,147
45,134
43,530
41,846
20,228
43,376
43,053
43,211
21,756
45,512
44,847
44,001
20,898
42,262
45,518
48,545
29,711
50,718
52,897
52,303
34,724
53,123
88,628
53,394
36,976
55,347
53,868
53,195
34,397
50,220
48,513
46,335
28,355
44,403
43,590
42,609
25,605
41,822
41,631
40,943
24,040
0
0
35,377
18,560
32,045
30,826
30,643
16,041
33,850
35,146
36,381
36,069
41,976
26,589
28,371
31,246
31,24628,37126,58941,97636,06936,38135,14633,85016,04130,64330,82632,04518,56035,3770024,04040,94341,63141,82225,60542,60943,59044,40328,35546,33548,51350,22034,39753,19553,86855,34736,97653,39488,62853,12334,72452,30352,89750,71829,71148,54545,51842,26220,89844,00144,84745,51221,75643,21143,05343,37620,22841,84643,53045,13419,147000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,873
0
0
0
28,804
0
0
0
31,197
0
-1
0
4,548
-1
0
-1
2,661
-1
-1
-1
7,715
0
0
0
1
0
9,880
5,079
0
05,0799,880010007,715-1-1-12,661-10-14,5480-1031,19700028,80400034,8730000000000000000000000000000000
> Total Liabilities 
0
0
0
39,333
36,301
35,083
33,139
38,110
35,649
40,182
35,809
42,741
40,448
45,989
35,005
36,697
32,784
43,985
42,476
46,755
42,236
53,913
54,738
64,391
59,578
106,357
58,317
62,272
54,285
47,172
46,854
50,345
49,801
56,646
58,073
68,081
61,715
48,437
53,528
62,880
62,397
56,266
59,117
99,248
91,950
82,172
95,799
88,973
83,787
71,089
80,924
97,192
99,765
88,561
86,740
114,968
100,350
87,995
96,630
107,777
107,77796,63087,995100,350114,96886,74088,56199,76597,19280,92471,08983,78788,97395,79982,17291,95099,24859,11756,26662,39762,88053,52848,43761,71568,08158,07356,64649,80150,34546,85447,17254,28562,27258,317106,35759,57864,39154,73853,91342,23646,75542,47643,98532,78436,69735,00545,98940,44842,74135,80940,18235,64938,11033,13935,08336,30139,333000
   > Total Current Liabilities 
0
0
0
24,796
22,698
22,496
21,567
25,776
22,978
27,174
22,466
29,252
27,142
32,867
31,360
33,227
29,488
30,883
30,383
39,002
35,490
36,926
39,696
51,275
48,408
43,550
51,036
55,271
47,564
42,396
43,190
47,793
48,362
44,318
46,670
57,581
52,903
40,374
45,278
55,380
54,167
48,709
52,188
71,447
63,925
56,657
61,928
59,477
56,474
51,539
62,585
77,603
81,187
70,803
69,491
99,822
90,152
80,859
92,259
94,284
94,28492,25980,85990,15299,82269,49170,80381,18777,60362,58551,53956,47459,47761,92856,65763,92571,44752,18848,70954,16755,38045,27840,37452,90357,58146,67044,31848,36247,79343,19042,39647,56455,27151,03643,55048,40851,27539,69636,92635,49039,00230,38330,88329,48833,22731,36032,86727,14229,25222,46627,17422,97825,77621,56722,49622,69824,796000
       Short-term Debt 
0
0
0
4,000
0
0
0
3,000
0
0
0
0
0
0
0
0
0
0
0
3,332
0
0
0
7,082
0
0
0
5,416
0
0
0
3,750
0
12,000
11,250
4,875
8,813
40,374
0
3,000
0
48,709
52,188
9,206
0
0
0
9,880
56,474
51,539
62,585
7,112
81,187
0
0
0
0
0
0
0
000000081,1877,11262,58551,53956,4749,8800009,20652,18848,70903,000040,3748,8134,87511,25012,00003,7500005,4160007,0820003,332000000000003,0000004,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,625
0
12,000
11,250
4,875
8,813
8,063
0
3,000
0
48,709
52,188
3,000
0
0
0
9,880
56,474
51,539
62,585
0
81,187
350
350
0
1,373
5,338
4,869
0
04,8695,3381,373035035081,187062,58551,53956,4749,8800003,00052,18848,70903,00008,0638,8134,87511,25012,00005,6250000000000000000000000000000000
       Accounts payable 
0
0
0
8,716
0
0
0
6,930
0
0
0
6,955
0
0
0
8,430
0
0
0
10,011
7,618
4,902
0
8,479
5,470
0
0
12,739
0
10,581
0
8,443
0
0
0
13,524
0
0
0
11,937
0
0
0
14,828
0
0
0
13,530
0
0
0
13,205
0
16,069
9,884
23,158
32,365
21,553
36,683
25,083
25,08336,68321,55332,36523,1589,88416,069013,20500013,53000014,82800011,93700013,5240008,443010,581012,739005,4708,47904,9027,61810,0110008,4300006,9550006,9300008,716000
       Other Current Liabilities 
0
0
0
12,080
22,698
22,496
21,567
15,846
22,978
27,174
22,466
22,297
27,142
32,867
31,360
24,797
29,488
30,883
30,383
25,659
27,872
32,024
39,696
35,714
42,938
43,550
51,036
37,116
47,564
31,815
43,190
35,600
48,362
44,318
46,670
39,182
52,903
40,374
45,278
40,443
54,167
44,620
49,461
47,413
63,925
56,657
61,928
36,067
56,474
43,122
55,171
57,286
81,187
47,035
54,308
69,564
0
52,075
0
1,413
1,413052,075069,56454,30847,03581,18757,28655,17143,12256,47436,06761,92856,65763,92547,41349,46144,62054,16740,44345,27840,37452,90339,18246,67044,31848,36235,60043,19031,81547,56437,11651,03643,55042,93835,71439,69632,02427,87225,65930,38330,88329,48824,79731,36032,86727,14222,29722,46627,17422,97815,84621,56722,49622,69812,080000
   > Long-term Liabilities 
0
0
0
14,537
13,603
12,587
11,572
12,334
12,671
13,008
13,343
13,489
13,306
13,122
3,645
3,470
3,296
13,102
12,093
7,753
6,746
16,987
15,042
13,116
11,170
62,807
7,281
7,001
6,721
4,776
3,664
2,552
1,439
12,328
11,403
10,500
8,812
8,063
8,250
7,500
8,230
7,557
6,929
27,801
28,025
25,515
33,871
29,496
27,313
19,550
18,339
19,589
18,578
17,758
17,249
15,145
10,198
7,136
4,371
13,493
13,4934,3717,13610,19815,14517,24917,75818,57819,58918,33919,55027,31329,49633,87125,51528,02527,8016,9297,5578,2307,5008,2508,0638,81210,50011,40312,3281,4392,5523,6644,7766,7217,0017,28162,80711,17013,11615,04216,9876,7467,75312,09313,1023,2963,4703,64513,12213,30613,48913,34313,00812,67112,33411,57212,58713,60314,537000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,657
29,232
27,077
19,483
18,186
17,079
15,290
13,501
13,501
10,020
8,025
6,369
4,150
0
04,1506,3698,02510,02013,50113,50115,29017,07918,18619,48327,07729,23230,6570000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
677
1,439
328
153
0
-1
0
0
0
570
-1
0
618
3,089
2,826
3,214
265
236
67
153
2,510
3,288
4,257
3,748
5,125
0
767
0
0
0076705,1253,7484,2573,2882,510153672362653,2142,8263,0896180-1570000-101533281,4396770000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,700
0
0
0
26,197
0
0
0
23,985
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000023,98500026,19700031,7000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
106,294
108,442
96,753
101,544
107,834
112,256
101,608
104,610
106,885
113,034
101,536
113,591
115,170
120,882
110,357
114,981
121,635
126,711
119,362
127,030
139,097
146,031
131,868
142,673
156,164
165,706
148,278
159,153
166,704
178,453
156,645
169,195
182,984
191,023
168,630
180,286
206,712
223,558
202,438
223,144
236,861
271,131
286,104
298,951
256,847
281,303
260,986
281,664
306,052
327,725
309,080
345,689
367,691
399,192
353,941
378,267
397,941
397,941378,267353,941399,192367,691345,689309,080327,725306,052281,664260,986281,303256,847298,951286,104271,131236,861223,144202,438223,558206,712180,286168,630191,023182,984169,195156,645178,453166,704159,153148,278165,706156,164142,673131,868146,031139,097127,030119,362126,711121,635114,981110,357120,882115,170113,591101,536113,034106,885104,610101,608112,256107,834101,54496,753108,442106,294000
   Common Stock
0
0
0
46,435
4,716
4,716
4,708
46,434
4,585
4,585
4,585
46,431
4,585
4,585
4,585
46,381
4,585
4,585
4,585
46,381
4,585
4,585
4,585
46,381
4,585
4,585
4,585
47,581
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
4,585
0
04,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,58547,5814,5854,5854,58546,3814,5854,5854,58546,3814,5854,5854,58546,3814,5854,5854,58546,4314,5854,5854,58546,4344,7084,7164,71646,435000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000-79,343000-63,782000-52,010000-46,360000-41,451000-37,226000-32,469000-28,283000-25,466000-22,625000-20,225000-17,924000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,172
41,852
44,172
44,172
44,172
44,172
44,172
44,172
44,172
41,852
44,172
44,172
44,172
0
044,17244,17244,17241,85244,17244,17244,17244,17244,17244,17244,17241,85244,1720000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
17,923
103,726
92,037
96,836
20,225
107,671
97,023
100,025
22,626
108,449
96,951
109,006
25,466
116,297
105,772
110,396
28,283
122,126
114,777
122,445
32,469
141,446
127,283
138,088
37,226
161,121
143,693
154,568
85,476
173,868
152,060
164,610
90,866
186,438
164,045
175,701
99,283
218,973
197,853
218,559
111,674
266,546
281,519
294,366
127,705
276,718
256,401
277,079
61,307
323,140
260,323
296,932
318,935
350,435
305,184
329,510
0
0329,510305,184350,435318,935296,932260,323323,14061,307277,079256,401276,718127,705294,366281,519266,546111,674218,559197,853218,97399,283175,701164,045186,43890,866164,610152,060173,86885,476154,568143,693161,12137,226138,088127,283141,44632,469122,445114,777122,12628,283110,396105,772116,29725,466109,00696,951108,44922,626100,02597,023107,67120,22596,83692,037103,72617,923000



Balance Sheet

Currency in NOK. All numbers in thousands.




Cash Flow

Currency in NOK. All numbers in thousands.




Income Statement

Currency in NOK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue521,109
Cost of Revenue-112,279
Gross Profit408,830408,830
 
Operating Income (+$)
Gross Profit408,830
Operating Expense-389,668
Operating Income131,44119,162
 
Operating Expense (+$)
Research Development0
Selling General Administrative51,884
Selling And Marketing Expenses0
Operating Expense389,66851,884
 
Net Interest Income (+$)
Interest Income3,275
Interest Expense-151
Other Finance Cost-285
Net Interest Income2,839
 
Pretax Income (+$)
Operating Income131,441
Net Interest Income2,839
Other Non-Operating Income Expenses0
Income Before Tax (EBT)135,212131,441
EBIT - interestExpense = -151
103,823
103,974
Interest Expense151
Earnings Before Interest and Taxes (EBIT)0135,363
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax135,212
Tax Provision-31,389
Net Income From Continuing Ops103,823103,823
Net Income103,823
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-2,839
 

Technical Analysis of Medistim
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medistim. The general trend of Medistim is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medistim's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Medistim ASA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 201.00 < 204.00 < 204.00.

The bearish price targets are: 178.50 > 178.50 > 176.00.

Tweet this
Medistim ASA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Medistim ASA. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Medistim ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Medistim ASA. The current macd is -2.46418513.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medistim price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Medistim. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Medistim price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Medistim ASA Daily Moving Average Convergence/Divergence (MACD) ChartMedistim ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Medistim ASA. The current adx is 21.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Medistim shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Medistim ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Medistim ASA. The current sar is 202.79.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Medistim ASA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Medistim ASA. The current rsi is 38.28. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Medistim ASA Daily Relative Strength Index (RSI) ChartMedistim ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Medistim ASA. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medistim price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Medistim ASA Daily Stochastic Oscillator ChartMedistim ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Medistim ASA. The current cci is -79.9031477.

Medistim ASA Daily Commodity Channel Index (CCI) ChartMedistim ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Medistim ASA. The current cmo is -31.01755903.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Medistim ASA Daily Chande Momentum Oscillator (CMO) ChartMedistim ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Medistim ASA. The current willr is -95.83333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Medistim ASA Daily Williams %R ChartMedistim ASA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Medistim ASA.

Medistim ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Medistim ASA. The current atr is 7.10654498.

Medistim ASA Daily Average True Range (ATR) ChartMedistim ASA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Medistim ASA. The current obv is -296,761.

Medistim ASA Daily On-Balance Volume (OBV) ChartMedistim ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Medistim ASA. The current mfi is 63.77.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Medistim ASA Daily Money Flow Index (MFI) ChartMedistim ASA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Medistim ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Medistim ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Medistim ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.277
Ma 20Greater thanMa 50188.900
Ma 50Greater thanMa 100196.740
Ma 100Greater thanMa 200203.990
OpenGreater thanClose188.500
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medistim with someone you think should read this too:
  • Are you bullish or bearish on Medistim? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medistim? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Medistim ASA

I send you an email if I find something interesting about Medistim ASA.


Comments

How you think about this?

Leave a comment

Stay informed about Medistim ASA.

Receive notifications about Medistim ASA in your mailbox!